Vol. 49 (December 11, 2017): Neurological Disorders

The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information. This week’s topic: Neurological Disorders 5 Journal Articles Disease Modifying Treatments and Symptomatic Drugs for Cognitive Impairment in Multiple Sclerosis: Where Do We Stand? Inventory of Real World Data Sources in Parkinson’s Disease Effect of Exercising at Minimum Recommendations of the Multiple Sclerosis Exercise Guideline Combined with Structured Education or Attention Control Education—Secondary Results of the Step It Up Randomized Controlled Trial Ocrelizumab Versus Placebo in Primary Progressive Multiple Sclerosis Expanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System 5 News Articles Advanced Practice Providers Treat Significantly More of Their Multiple Sclerosis Patients with Monoclonal Antibody Disease-Modifying Therapies Compared to Neurologists in the United States Study: Parkinson’s Disease Progression Can Be Slowed with Vigorous Exercise Restless Sleep Might Be an Early Sign of Parkinson’s Disease California Resident Gets Life-Changing Treatment for Multiple Sclerosis in Russia New Gene Therapy Could Regenerate Brain Tissue, Fix Neurologi...
Source: Innovations in Clinical Neuroscience - Category: Neuroscience Authors: Tags: The Neuroscience Report neurological disorders Source Type: research